JARDIANCE under watch: new study tracks kidney drug safety in korean patients

NCT ID NCT06287073

First seen Feb 01, 2026 · Last updated May 12, 2026 · Updated 11 times

Summary

This study looked at how safe and effective JARDIANCE (empagliflozin) is for Korean adults with chronic kidney disease (CKD) in everyday medical practice. Researchers monitored 299 patients for side effects and checked changes in a key kidney health marker (urine albumin-creatinine ratio) after 12 and 24 weeks of treatment. The goal was to confirm the drug's safety and benefit in a real-world setting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chonnam National University Hospital

    Gwangju, 61469, South Korea

  • Chungbuk National University Hospital

    Cheongiu, 28644, South Korea

  • Hallym University Sacred Heart Hospital

    Anyang, 07441, South Korea

  • Inje University Ilsan Paik Hospital

    Goyang, 10380, South Korea

  • Korea University Anam Hospital

    Seoul, 02841, South Korea

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Seoul National University Hospital

    Seoul, 03080, South Korea

  • Soonchunhyang University Hospital Seoul

    Seoul, 04401, South Korea

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    Seoul, 03312, South Korea

  • The Catholic University of Korea, Yeouido St.Mary's Hospital

    Seoul, 07345, South Korea

  • Ulsan University Hospital

    Ulsan, 44033, South Korea

  • Yonsei University Wonju Severance Christian Hospital

    Gangwon, 26426, South Korea

Conditions

Explore the condition pages connected to this study.